Medipure Holdings Inc.
Medipure is developing an extensive network of strategic partnerships with extensive experience in developing cannabinoids, medicines containing controlled substances, as well as plant-based prescription pharmaceutical products. Medipure will attempt to bring novel prescription medicines to market, providing patients with serious conditions valuable solutions that make a real difference to quality of life.
Medipure Holdings Inc. (MDH)
August 16, 2016
The common shares of Medipure Holdings Inc. will be delisted at the market close today, August 16, 2016.
Medipure Holdings is currently suspended.
Date: Market close, August 16, 2016
If you have any questions or require further information, or to be removed from the mailing list please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com